标普和纳斯达克内在价值 联系我们

Biostar Pharmaceuticals, Inc. BSPM OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CN • USD

SharesGrow Score
29/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Biostar Pharmaceuticals, Inc. (BSPM) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 28/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
29/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
~
过去
50/100
→ Income
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
护城河
21/100
→ Income
成长
15/100
→ Income
收入
10/100
→ Income

估值概览 — BSPM

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-2.50
每股账面价值$0.00
每股营收$1.04
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2007 $3.99 $15.89M $3.96M 25%
2008 $4.62 $33.91M $6.69M 19.7%
2009 $6.72 $53.32M $10.5M 19.7%
2010 $13.23 $80.22M $17.38M 21.7%
2011 $9.17 $91.97M $12.17M 13.2%
2012 $-14.63 $49.32M $-20M -40.5%
2013 $0.49 $52.73M $809.05K 1.5%
2014 $2.30 $61.42M $4.85M 7.9%
2015 $-11.36 $27.13M $-25.11M -92.6%
2016 $-2.50 $2.38M $-5.7M -239%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言